Results 1 to 10 of about 11,500 (220)

Outpatient Parenteral Antimicrobial Therapy [PDF]

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2013
#### Summary points Outpatient parenteral antimicrobial therapy (OPAT) allows patients to be given intravenous antibiotics in the community rather than as an inpatient. First developed in the 1970s in the US for the treatment of children with cystic fibrosis,1 OPAT has expanded substantially and is now standard practice in many countries.2 3 In the UK,
Kevin B Laupland, Louis Valiquette
doaj   +7 more sources

Assessment of risk factors associated with outpatient parenteral antimicrobial therapy complications [PDF]

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology, 2022
Background: Outpatient parenteral antimicrobial therapy (OPAT) is used in the outpatient setting to treat infectious conditions that require a prolonged course of antimicrobials.
Christina Kaul   +8 more
doaj   +5 more sources

Outpatient Parenteral Antimicrobial Therapy (OPAT) in Italy: A Scoping Review. [PDF]

open access: yesInfect Dis Ther
Introduction Outpatient parenteral antimicrobial therapy (OPAT) enables effective infection management outside hospital settings, offering clinical and economic benefits.
Moreal C   +17 more
europepmc   +2 more sources

Recommendations for outpatient parenteral antimicrobial therapy in Brazil

open access: yesBrazilian Journal of Infectious Diseases, 2017
A panel of national experts was convened by the Brazilian Infectious Diseases Society in order to determine the recommendations for outpatient parenteral antimicrobial therapy (OPAT) in Brazil.
Priscila R. Oliveira   +3 more
doaj   +5 more sources

Cost avoidance analysis of outpatient parenteral antimicrobial therapy (OPAT) plan reconciliation for patients enrolled in value-based payment models at an academic hospital [PDF]

open access: yesAntimicrob Steward Healthc Epidemiol
We previously characterized a reduction in unscheduled care following implementation of ID pharmacist review of outpatient parenteral antimicrobial therapy plans for patients discharging from acute care.
Ross J   +8 more
europepmc   +2 more sources

Outpatient parenteral antimicrobial therapy in Brazil

open access: yesTherapeutic Advances in Infectious Disease, 2023
Priscila R Oliveira   +3 more
doaj   +3 more sources

The Impact of a Structured Outpatient Parenteral Antimicrobial Therapy (OPAT) Programme on Quality of Care, Optimisation of Antimicrobial Use, and Healthcare Costs: A Retrospective Cohort Study. [PDF]

open access: yesAntibiotics (Basel)
Background/Objectives: In 2022, Spaarne Gasthuis hospital implemented an outpatient parenteral antimicrobial therapy (OPAT) programme, including mandatory infectious disease (ID) specialist assessment and integrated structured workflow, aiming to improve
Manders IG   +8 more
europepmc   +2 more sources

Risk Factors for Hospital Readmission Following Outpatient Parenteral Antimicrobial Therapy (OPAT). [PDF]

open access: yesInfect Dis Ther
Introduction A main goal of outpatient parenteral antibiotic therapy (OPAT) is to streamline patient care and minimize time spent in the inpatient hospital setting.
Yousif M   +3 more
europepmc   +2 more sources

Outpatient Parenteral Antimicrobial Therapy for Infective Endocarditis—Model of Care

open access: yesAntibiotics, 2023
Infective endocarditis (IE) is a serious infectious disease with significant mortality and morbidity placing a burden on healthcare systems. Outpatient antimicrobial therapy in selected patients has been shown to be safe and beneficial to both patients ...
Dylan Rajaratnam, Rohan Rajaratnam
doaj   +1 more source

Taking the route less traveled: on the way to COpAT

open access: yesTherapeutic Advances in Infectious Disease, 2023
Antimicrobial therapy is an essential practice within medicine. Over the last 4 years, complex outpatient antimicrobial therapy (COpAT) with oral antimicrobials has become a rapidly developing area of practice and is non-inferior to outpatient parenteral
Margaret Pertzborn   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy